These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
85 related articles for article (PubMed ID: 1889282)
1. Neoadjuvant therapy of lung cancer. Patterson GA Chest; 1991 Sep; 100(3):845-6. PubMed ID: 1889282 [No Abstract] [Full Text] [Related]
2. A retrospective study of concurrent chemoradiation using mitomycin, vinblastine and cisplatin chemotherapy for non-small cell lung cancer. Newman G Clin Oncol (R Coll Radiol); 2009 Nov; 21(9):728. PubMed ID: 19628378 [No Abstract] [Full Text] [Related]
3. Surgery following neoadjuvant MPV chemotherapy (mitomycin, cisplatin, vinblastine) in locally advanced (IIIa and IIIb) non-small cell lung cancer. Carretta A; Chiesa G; Zannini P; Villa E; Verusio C; Fumagalli F; Melloni G; Grossi A Eur J Cardiothorac Surg; 1994; 8(9):457-61. PubMed ID: 7811477 [TBL] [Abstract][Full Text] [Related]
4. [Recent topics in surgical treatment of lung cancer]. Yoshino I; Shoji F; Kometani T; Maehara Y Gan To Kagaku Ryoho; 2007 Aug; 34(8):1207-10. PubMed ID: 17847582 [No Abstract] [Full Text] [Related]
5. [Bronchial arterial infusion chemotherapy (BAI) and BAI with radiotherapy in advanced non-small cell lung cancer]. Sato T; Mitsuhata N; Fujiwara K; Miyake M; Jyojya I; Ono T Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 1):719-22. PubMed ID: 2451474 [No Abstract] [Full Text] [Related]
6. [Mitomycin C, adriamycin and vinblastine after induction with cisplatin and VP-16 in the treatment of non-small cell lung carcinoma]. De Marinis A; Mugnaini L; Antilli A; Mollica C; Mecarocci D; Conte S; Salvati F G Ital Chemioter; 1985; 32(1):73-5. PubMed ID: 3007255 [No Abstract] [Full Text] [Related]
7. Pathologic complete response in advanced non-small-cell lung cancer following preoperative chemotherapy: implications for the design of future non-small-cell lung cancer combined modality trials. Pisters KM; Kris MG; Gralla RJ; Zaman MB; Heelan RT; Martini N J Clin Oncol; 1993 Sep; 11(9):1757-62. PubMed ID: 8394881 [TBL] [Abstract][Full Text] [Related]
8. Combined treatment with chemotherapy and neutron irradiation for limited non-small-cell lung cancer: a Southwest Oncology Group Study. Livingston RB; Griffin BR; Higano CS; Laramore GE; Rivkin SE; Goldberg RS; Schulman SF J Clin Oncol; 1987 Nov; 5(11):1716-24. PubMed ID: 2824705 [TBL] [Abstract][Full Text] [Related]
9. [The effect of multimodality induction therapy for locally advanced non-small cell lung cancer]. Yamada T; Nakashima Y; Tanahashi M; Hikosaka Y; Yoshitomi H; Niwa H Kyobu Geka; 2005 Oct; 58(11):969-75. PubMed ID: 16235845 [TBL] [Abstract][Full Text] [Related]
10. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935. Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112 [TBL] [Abstract][Full Text] [Related]
11. Randomized phase 2 evaluation of preoperative radiation therapy and preoperative chemotherapy with mitomycin, vinblastine, and cisplatin in patients with technically unresectable stage IIIA and IIIB non-small cell cancer of the lung. LCSG 881. Wagner H; Lad T; Piantadosi S; Ruckdeschel JC Chest; 1994 Dec; 106(6 Suppl):348S-354S. PubMed ID: 7988262 [TBL] [Abstract][Full Text] [Related]
12. Neoadjuvant chemotherapy and radiotherapy followed by surgery in stage IIIA non-small-cell carcinoma of the lung: report of a Cancer and Leukemia Group B phase II study. Strauss GM; Herndon JE; Sherman DD; Mathisen DJ; Carey RW; Choi NC; Rege VB; Modeas C; Green MR J Clin Oncol; 1992 Aug; 10(8):1237-44. PubMed ID: 1321893 [TBL] [Abstract][Full Text] [Related]
13. [Evaluation of prognostic nutritional index in chemotherapy of lung cancer]. Nakai Y; Saito J Gan To Kagaku Ryoho; 1991 Mar; 18(3):493-6. PubMed ID: 1706172 [No Abstract] [Full Text] [Related]
14. Analysis of a novel protocol of combined induction chemotherapy and concurrent chemoradiation in unresected non-small-cell lung cancer: a ten-year experience with vinblastine, Cisplatin, and radiation therapy. Waters E; Dingle B; Rodrigues G; Vincent M; Ash R; Dar R; Inculet R; Kocha W; Malthaner R; Sanatani M; Stitt L; Yaremko B; Younus J; Yu E Clin Lung Cancer; 2010 Jul; 11(4):243-50. PubMed ID: 20630826 [TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant mitomycin C, cisplatin, and infusion vinblastine in locally and regionally advanced non-small cell lung cancer: problems and progress from the perspective of long-term follow-up. Spain RC Semin Oncol; 1988 Jun; 15(3 Suppl 4):6-15. PubMed ID: 2839905 [TBL] [Abstract][Full Text] [Related]
16. [Dose intensity chemotherapy in lung cancer]. Takada M; Fukuoka M; Negoro S; Masuda N; Kudo S Gan To Kagaku Ryoho; 1990 Oct; 17(10):2005-12. PubMed ID: 1699498 [TBL] [Abstract][Full Text] [Related]
17. [Current perspectives in the management of non-small cell lung cancer]. Fujita J; Saijo N Gan No Rinsho; 1985 Apr; 31(4):355-62. PubMed ID: 2409308 [TBL] [Abstract][Full Text] [Related]
18. Effect of amifostine on toxicities associated with sequential chemotherapy and radiation therapy for unresectable non-small-cell lung cancer: results of a phase II trial. Tannehill SP; Mehta MP; Larson M; Storer B; Pellet J; Kinsella TJ; Schiller JH J Clin Oncol; 1997 Aug; 15(8):2850-7. PubMed ID: 9256128 [TBL] [Abstract][Full Text] [Related]